Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quanbo Zhou

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Translational Medicine|May 8, 2015
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patientsGaojie Liu, Jie Zhu, Menglei Yu, et al.
Cell Death and Differentiation|February 19, 2025
CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancerXiaowei He, Ji Liu, Yifan Zhou, et al.
Diabetologia|February 1, 2015
Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinomaWenchao Gao, Yu Zhou, Qingyan Li, et al.
Cell Metabolism|April 20, 2024
QDPR deficiency drives immune suppression in pancreatic cancerJi Liu, Xiaowei He, Shuang Deng, et al.
Nature Communications|October 10, 2023
CSTF2 mediated mRNA N<sup>6</sup>-methyladenosine modification drives pancreatic ductal adenocarcinoma m<sup>6</sup>A subtypesYanfen Zheng, Xingyang Li, Shuang Deng, et al.
Cancer Research|August 9, 2024
KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma ProgressionZilan Xu, Yifan Zhou, Shaoqiu Liu, et al.
Journal of Robotic Surgery|June 1, 2026
Interpretable machine learning model for predicting operative difficulty in robotic total mesorectal excision for mid-low rectal cancerHaoran Mao, Shuai Ma, Yang Li, et al.
Cancer Research|June 16, 2023
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic CancerJiachun Su, Rui Li, Ziming Chen, et al.
Cancer Communications (London, England)|December 29, 2022
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trialQing Lin, Shangyou Zheng, Xianjun Yu, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Translational Medicine|May 8, 2015
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patientsGaojie Liu, Jie Zhu, Menglei Yu, et al.
Cell Death and Differentiation|February 19, 2025
CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancerXiaowei He, Ji Liu, Yifan Zhou, et al.
Diabetologia|February 1, 2015
Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinomaWenchao Gao, Yu Zhou, Qingyan Li, et al.
Cell Metabolism|April 20, 2024
QDPR deficiency drives immune suppression in pancreatic cancerJi Liu, Xiaowei He, Shuang Deng, et al.
Nature Communications|October 10, 2023
CSTF2 mediated mRNA N<sup>6</sup>-methyladenosine modification drives pancreatic ductal adenocarcinoma m<sup>6</sup>A subtypesYanfen Zheng, Xingyang Li, Shuang Deng, et al.
Cancer Research|August 9, 2024
KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma ProgressionZilan Xu, Yifan Zhou, Shaoqiu Liu, et al.
Journal of Robotic Surgery|June 1, 2026
Interpretable machine learning model for predicting operative difficulty in robotic total mesorectal excision for mid-low rectal cancerHaoran Mao, Shuai Ma, Yang Li, et al.
Cancer Research|June 16, 2023
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic CancerJiachun Su, Rui Li, Ziming Chen, et al.
Cancer Communications (London, England)|December 29, 2022
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trialQing Lin, Shangyou Zheng, Xianjun Yu, et al.
Pageof 9